Soft Capsule Manufacturing Enhances Bioavailability

GC Green Cross 'Taksen Series'

[Asia Economy Reporter Seo So-jeong] GC Green Cross's Taksen series is a nonsteroidal anti-inflammatory drug (NSAIDs) that shows excellent effects in pain relief and anti-inflammatory action. In particular, it has a product lineup with various ingredients such as naproxen, ibuprofen, and dexibuprofen, allowing users to choose according to their symptoms.

Additionally, it is made using the patented soft capsule manufacturing method called Neosol, which has a high absorption rate in the body, enabling fast effects. Being in liquid form, it is easy to take and leaves no residue in the stomach, reducing the heartburn side effect common with tablet forms.

The Taksen series consists of a total of five product groups. The representative product, 'Taksen,' contains naproxen as the main ingredient and is characterized by long-lasting pain relief and anti-inflammatory effects. Along with this, there is 'Taksen400,' which enhances fever-reducing and pain-relieving effects by increasing the ibuprofen content, and 'Taksen Eve,' which helps diuretic action and reduces body swelling through the combined action of ibuprofen and paracetamol, aiding in the relief of menstrual pain symptoms in women.

Last year, 'Taksen MG,' which minimizes gastrointestinal disorders caused by painkillers, and 'Taksen Dexi,' which shows rapid effects at low doses, were also launched. 'Taksen MG' contains magnesium along with ibuprofen, helping to alleviate heartburn caused by painkillers.

'Taksen Dexi' contains dexibuprofen, the active part of ibuprofen, as the main ingredient. It is characterized by showing equivalent pain relief effects with 50% less dosage than ibuprofen. A GC Green Cross official stated, "The Taksen series is a customized product that helps with common pains experienced by modern people."

This content was produced with the assistance of AI translation services.